agn 193109 has been researched along with bromochloroacetic acid in 1 studies
| Studies (agn 193109) | Trials (agn 193109) | Recent Studies (post-2010) (agn 193109) | Studies (bromochloroacetic acid) | Trials (bromochloroacetic acid) | Recent Studies (post-2010) (bromochloroacetic acid) |
|---|---|---|---|---|---|
| 33 | 0 | 1 | 22,219 | 258 | 3,378 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, C; Arefieg, T; Chandraratna, RA; DiSepio, D; Eckert, RL; Johnson, A; Klein, ES; Krasinski, G; Nagpal, S; Thacher, SM | 1 |
1 other study(ies) available for agn 193109 and bromochloroacetic acid
| Article | Year |
|---|---|
Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes.
Topics: Calcium-Binding Proteins; Calgranulin A; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Keratinocytes; Keratins; Matrix Metalloproteinase 3; Naphthalenes; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; Transglutaminases | 1999 |